Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...

After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...

Currently, kidney transplantation is the most effective treatment to ensure survival and improve the quality of life of ...

Rahul Banerjee, MD, FACP, assistant professor in the Division of Hematology and Oncology, University of Washington, dissects the limited data on T-cell therapies for multiple myeloma, infectious ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

Lyric Porter’s battle with sickle cell began almost immediately after birth. Here's how a groundbreaking treatment improved ...

Between devices, medications and therapies, included cell replacement, local families in the T1D fight say they're optimistic ...